PeerVoice Immunology & Infectious Disease Video PeerVoice

Visit https://www.peervoice.com/HUM860 to view the entire programme with slides. After completing “Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making”, participants will be able to: Describe key information regarding the disease process and course following the diagnosis of generalized pustular psoriasis (GPP); Address common concerns raised by patients with GPP; and Develop appropriate treatment plans with patients for the management of GPP.

Visit https://www.peervoice.com/QQB860 to view the entire programme with slides. After completing “Mohamed El-Hussein, RN, PhD, NP / Caitlin Carreau, MN, RN(EC) - At the Forefront of Cancer Prevention: Nursing Strategies to Optimize HPV Immunization”, participants will be able to: Describe the various cancer risks in adults that have been linked to human papillomavirus (HPV) infection; Discuss the latest clinical evidence with HPV vaccines; Discuss HPV prevention measures and how nurses can integrate HPV prevention in their clinical practice; and Outline nursing strategies to improve HPV vaccination rates in adults through multidisciplinary collaboration.

Visit https://www.peervoice.com/BBT860 to view the entire programme with slides. After completing “Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?”, participants will be able to: Describe the benefits and limitations of current disease-modifying strategies in multiple sclerosis (MS); Discuss the role of Bruton’s tyrosine kinase (BTK) in the pathological processes associated with disease progression in patients with MS; and Use clinical data to evaluate on-target and off-target effects of emerging BTK inhibitors for patients with MS in the context of current clinical management.

Visit https://www.peervoice.com/RVW860 to view the entire programme with slides. After completing “Simon Couillard, MD, MSc - Improving Outcomes in Severe Eosinophilic Asthma: Translating Recent Evidence With Biologics Into Patient Care”, participants will be able to: Discuss the pathogenic mechanisms in severe eosinophilic asthma and the role of biomarkers in informing treatment; Describe the role of biologics in improving patient outcomes and their impact on background medication use; and Outline the most recent real-world evidence with biologics for severe eosinophilic asthma and its clinical implications for patient management.

Visit https://www.peervoice.com/BSG860 to view the entire programme with slides. After completing “George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action”, participants will be able to: Summarise the evidence supporting the need for the current 2024 COVID-19 vaccination campaign for older adults and vulnerable individuals; and Outline the key recommendations by the World Health Organization (WHO) and European Centre for Disease Prevention and Control (ECDC) on the current 2024 COVID-19 vaccination roll-out.

Visit https://www.peervoice.com/DPR860 to view the entire programme with slides. After completing “Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care”, participants will be able to: Discuss how technology has been used to optimise care of chronic diseases; Recognise the needs for simplifying the management of immunoglobulin therapy using device and digital technologies; and Identify technologies that are in development to support patient-integrated care for those requiring immunoglobulin therapy and key considerations for their implementation.